Find another Doctor or Researcher

A photo of Adrienne M. Hammill.
High Res

Adrienne M. Hammill, MD, PhD

Director, Hereditary Hemorrhagic Telangiectasia (HHT) Center

Director, Sturge-Weber Center of Excellence

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636-0673

Email adrienne.hammill@cchmc.org

Clinical Interests
Hide
Hemangiomas and vascular malformations; genetic predispositions to cancer
Biography
Hide
Dr. Adrienne M. Hammill is trained in pediatrics and hematology/oncology and is particularly interested in bringing new and/or better medical therapy options to the treatment of vascular anomalies. She is one of the medical physicians for the Hemangioma and Vascular Malformations team. She obtained her schooling at the University of Texas Southwestern and completed her residency and fellowship here at Cincinnati Children’s Hospital Medical Center. She is a dedicated professional and strives to improve the treatment for her patients. Cincinnati Children’s has been named a site for the brain vascular malformations consortium, which is a clinical research group funded by National Institutes of Health and the rare disease network and more recently a SWF Center of Excellence. She has developed a broader interest in Brain Vascular Malformations, and now heads our HHT Center and participates in the Cerebrovascular Clinic housed in Neurosurgery as well.
Education and Training
Hide

MD: University of Texas Southwestern Medical School, Dallas, TX, 2004.

PhD: University of Texas Southwestern Graduate School of Biomedical Sciences, Dallas, TX, 2004.

Residency: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.

Fellowship: Cincinnati Children’s Hospital Medical Center.

Certifications: Pediatrics, 2008; Pediatric Hematology Oncology, 2011.

Publications
Hide

View PubMed Publications

Hammill AM, Wentzel MS, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011 Dec 1; 57(6):1018-1024.

Drolet BA, Trenor CC, Brandao L, Chiu YE, Chun RH, Dasgupta R, Garzon MC, Hammill AM, Johnson CM, Tlougan B, Blei F, David M, Elluru R, Frieden IJ, Friedlander SF, Iacobas I, Jensen JN, King DM, Lee MT, Nelson S, Patel M, Pope E, Powell J, Seefeldt M, Siegel DH, Kelly M, Adams DM. Consensus –derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013 Jul; 163(1):285-91.

Jeng MR, Fuh B, Blatt J, Gupta A, Merrow AC, Hammill A, Adams D. Malignant transformation of infantile hemangioma to angiosarcoma: Response to chemotherapy with bevacizumab. Pediatr Blood Cancer. 2014 Nov; 61(11): 2115-7.

Adams D, Hammill A. Other vascular tumors. Sem Ped Surg. 2014 Aug; 23(4) 173-7.

Burkes SA, Adams DM, Hammill AM, Chute C, Eaton KP, Welge JA, Wickett RR, Visscher MO. Skin Imaging Modalities Quantify Progression and Stage of Infantile Hemangiomas. Br J Dermatol. 2015 Sep; 173(3):838-41.

Adams DM, Hammill AM, Mobberley-Schuman PS, Trenor CC. Comment on: Steroid-resistant kaposiform hemangioendothelioma: A retrospective study of 37 patients treated with vincristine and long-term follow-up. Pediatr Blood Cancer. 2015 Nov; 62(11):2056.

Related Professionals

Donate Now

3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462

New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479

© 1999-2016 Cincinnati Children's Hospital Medical Center. All rights reserved.

Visit U.S. News site. Best Places to Work Logo